Table 2.
Percentage of positive responses by MDT for the six selected criteria (2017 MDT member survey)
| C=Combined results from 12 teams | Multidisciplinary teams | ||||||||||||
| C | 7 | 10 | 12 | 9 | 8 | 1 | 3 | 5 | 6 | 4 | 2 | 11 | |
| Does the MDT have TORs or guidelines to guide the conduct of the meetings? (yes/no) | 16 | 30 | 43 | 8 | 10 | 9 | 36 | 25 | 20 | 0 | 0 | 0 | 0 |
| Are there established criteria for referral of patients to MDT meetings? (yes/no) | 26 | 70 | 43 | 38 | 50 | 36 | 18 | 25 | 0 | 8 | 0 | 10 | 10 |
| Is there a follow-up process to check whether referrals from the MDT are actually made? (yes/no) | 14 | 30 | 57 | 8 | 30 | 18 | 0 | 0 | 10 | 0 | 0 | 0 | 0 |
| Does the MDT use clinical practice guidelines or standard treatment protocols relevant to the diagnosis, treatment and care of patients with cancer? (always or usually) | 63 | 80 | 65 | 69 | 80 | 81 | 100 | 63 | 30 | 58 | 50 | 40 | 30 |
| Does the MDT routinely collect the time from diagnosis to definitive treatment? (yes/no) | 10 | 20 | 14 | 31 | 33 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 |
| Are internal audits conducted to confirm that treatment decisions match current best practice? (yes/no) | 7 | 20 | 14 | 8 | 0 | 9 | 9 | 0 | 10 | 0 | 10 | 0 | 0 |
MDT, multidisciplinary team; TOR, Terms of Reference.